Q32 Bio (QTTB) Long-Term Investments (2022 - 2025)
Q32 Bio (QTTB) posted quarterly Long-Term Investments of $2.5 million for Q1 2025, down 46.53% year-over-year from $4.7 million in Q1 2024, and down 2.85% quarter-over-quarter from $2.6 million in Q4 2024.
Q32 Bio (QTTB) Long-Term Investments (2022 - 2025) Analysis & Trends
Q32 Bio's Long-Term Investments history runs 4 years deep, the most recent figure standing at $2.5 million for Q1 2025.
- In Q1 2025, Long-Term Investments fell 46.53% year-over-year to $2.5 million; the TTM figure through Mar 2025 stood at $2.5 million (down 46.53% YoY), while the FY2024 annual figure was $2.6 million, changed N/A from the prior year.
- Long-Term Investments for Q1 2025 stood at $2.5 million, down from $2.6 million in the prior quarter.
- The five-year high for Long-Term Investments was $30.6 million in Q1 2022, with the low at $2.5 million in Q1 2025.
- The 4-year median for Long-Term Investments is $15.6 million (2023), against an average of $15.2 million.
- The sharpest annual moves came in 2023 and 2024: Long-Term Investments fell 24.93% in 2023, then tumbled 81.37% in 2024.
- Q32 Bio's Long-Term Investments stood at $25.8 million in 2022, then sank by 45.93% to $14.0 million in 2023, then sank by 81.37% to $2.6 million in 2024, then fell by 2.85% to $2.5 million in 2025.
- Business Quant data shows QTTB's Long-Term Investments at $2.5 million in Q1 2025, $2.6 million in Q4 2024, and $2.6 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 5.79 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 9.83 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 372.10 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 22.17 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | Q32 Bio | 359.61 Mn | 253.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 2.53 Mn |
| Dec 31, 2024 | 2.60 Mn |
| Sep 30, 2024 | 2.60 Mn |
| Jun 30, 2024 | 3.28 Mn |
| Mar 31, 2024 | 4.72 Mn |
| Sep 30, 2023 | 13.96 Mn |
| Jun 30, 2023 | 17.32 Mn |
| Mar 31, 2023 | 23.00 Mn |
| Dec 31, 2022 | 25.81 Mn |
| Sep 30, 2022 | 27.13 Mn |
| Jun 30, 2022 | 29.30 Mn |
| Mar 31, 2022 | 30.64 Mn |